Tags: Cancer | liver | cancer | drug | succeeds | late-stage | trial

Liver Cancer Drug Succeeds in Late-Stage Trial

Liver Cancer Drug Succeeds in Late-Stage Trial
(Copyright iStock)

Thursday, 05 April 2018 09:09 AM

Eli Lilly and Co on Wednesday said its drug Cyramza being tested as a treatment for liver cancer patients, who did not respond to prior therapy, met the main goal in a late-stage trial.

The drug, being studied as a single therapy in a select population of liver cancer patients, also met the secondary goal of delaying progression of the disease.

Cyramza is already approved to treat other forms of cancer. Lilly said it intends to begin filing for marketing approval of the drug for the liver cancer indication in mid-2018.

© 2019 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
Eli Lilly and Co on Wednesday said its drug Cyramza being tested as a treatment for liver cancer patients, who did not respond to prior therapy, met the main goal in a late-stage trial.The drug, being studied as a single therapy in a select population of liver cancer...
liver, cancer, drug, succeeds, late-stage, trial
91
2018-09-05
Thursday, 05 April 2018 09:09 AM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved